Otc - Active Ingredient
Magnesium Ascorbyl Phosphate
K Oxiderm Op Post Procedure Skin Care Bruise
FDA Label NDC 71588-0011
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Ezekielcosmetic Co., Ltd for the product K Oxiderm Op Post Procedure Skin Care Bruise (NDC 71588-0011). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
water, propylene glycol, alcohol etc
Otc - Purpose
Reduces Discoloration on skin
Otc - Keep Out Of Reach Of Children
keep out of reach of the children
Indications & Usage
for 4~5 days before cosmetic application, apply thinly twice a day, morning and night, after cleansing the skin
apply K oxiderm OP cream right after cosmetic application
K oxiderm OP cream is recommended for 10 to 15 days as preparatory skin care before and after surgical and medical cosmetic procedure
Warnings
1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other skin irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight
2. Do not use on open wounds, eczema, and other skin irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight
4. Use as avoiding eye areas.
Dosage & Administration
for external use only
Package Label.Principal Display Panel
Label (Label)
* Please review the disclaimer below.
